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ABSTRACT  
It has been well established that excessive levels of glucose and palmitate lower glucose-stimulated 
insulin secretion (GSIS) by pancreatic beta cells. This beta cell ‘glucolipotoxicity’ is possibly 
mediated by mitochondrial dysfunction, but involvement of bioenergetic failure in the pathological 
mechanism is subject of ongoing debate. We show here that increased palmitate levels impair GSIS 
before altering mitochondrial function. We demonstrate that GSIS defects arise from increased 
insulin release under basal conditions in addition to decreased insulin secretion under glucose-
stimulatory conditions. Real-time respiratory analysis of intact mouse pancreatic islets reveals that 
mitochondrial ATP synthesis is not involved in the mechanism by which basal insulin is elevated. 
Equally, mitochondrial lipid oxidation and production of reactive oxygen species do not contribute 
to increased basal insulin secretion. Palmitate does not affect KCl-induced insulin release at a basal 
or stimulatory glucose level, but elevated basal insulin release is attenuated by palmitoleate and 
associates with increased intracellular calcium. These findings deepen our understanding of beta 
cell glucolipotoxicity and reveal that palmitate-induced GSIS impairment is disconnected from 
mitochondrial dysfunction, a notion that is important when targeting beta cells for the treatment of 
diabetes and when assessing islet function in human transplants. 
SUMMARY STATEMENT  
Mitochondrial dysfunction associates with obesity-related pancreatic beta cell failure, but the 
causality of this association is unclear. In this paper we show that palmitate-induced impairment of 
insulin secretion precedes mitochondrial respiratory defects in isolated mouse islets. 
SHORT TITLE 
Mitochondrial involvement in beta cell glucolipotoxicity 
KEYWORDS 
Pancreatic beta cells; glucolipotoxicity; mitochondria; oxidative phosphorylation; Type 2 diabetes; 
obesity 
ABBREVIATIONS 
DAPI, 4',6-diamidino-2-phenylindole; Fura-2AM, Fura-2-acetoxymethyl; FBS, fetal bovine serum; 
GSIS, glucose-stimulated insulin secretion; HEPES, 4-(2-hydroxyethyl)-1-piperazineethanesulfonic 
acid; KATP channel, ATP-sensitive potassium channel; MnTMPyP, Mn(III)tetrakis(1-methyl-4-
pyridyl) porphyrin pentachloride; NEFA, non-esterified fatty acids; OCR, oxygen consumption 
rate; ROS, reactive oxygen species; UCP2, uncoupling protein-2 
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INTRODUCTION 
Type 2 diabetes affects over 500 million people worldwide [1] and it is generally accepted that 
obesity is a major risk factor in the development of this metabolic disease [2]. The obese state is 
characterised by high NEFA levels, palmitate in particular, that contribute to pancreatic beta cell 
dysfunction and are thus partly responsible for the chronic hyperglycaemia that defines diabetes [3-
5]. When blood glucose levels rise, healthy beta cells increase their oxidative glucose catabolism, 
which leads to a rise in the cytoplasmic ATP/ADP ratio and, consequently, to closure of KATP 
channels, depolarisation of the plasma membrane potential, opening of voltage-gated Ca2+ channels, 
influx of Ca2+ and the eventual exocytosis of insulin-containing granules [6]. Mitochondria are 
essential for this GSIS as they couple the oxidation of glucose-derived reducing equivalents to the 
synthesis of ATP and thus provide a key signal in the canonical GSIS pathway. Mitochondria also 
generate ROS that have been implicated in insulin secretion [7-9] and produce other non-canonical 
signals that amplify GSIS [10]. 
In line with studies on human and mouse pancreatic islets [11,12], we have recently reported that 
palmitate exposure in the presence of a glucose surplus dampens GSIS in INS-1E insulinoma cells 
[13,14]. This GSIS impairment coincides with mitochondrial defects in oxidative phosphorylation 
[13,14]. Moreover, we have shown that palmitate-induced mitochondrial superoxide formation 
underlies NEFA-provoked INS-1E cell loss [15]. This cell loss can be prevented by palmitoleate, 
the monounsaturated equivalent of palmitate [15]. Mitochondria thus associate with several aspects 
of beta cell damage that is caused by ‘glucolipotoxicity’. More generally, mitochondrial function 
has been identified as promising predictor of functional islet integrity, and ‘bioenergetic health’ 
indeed correlates well with positive clinical outcomes in islet transplantation trials [16]. Dependable 
predictions of islet functionality would clearly benefit transplantation protocols, which is why we 
set out to further explore the reliability of mitochondrial function as potential biomarker of islet 
health. 
Over recent years, extracellular flux (XF) measurement has become fairly routine for probing real-
time bioenergetics of cultured cells [17] and the approach has been adopted to measure islet 
respiration [18]. In this study, we used XF technology to quantify effects of palmitate exposure on 
the bioenergetics of intact isolated mouse islets. We show that GSIS defects emerge without any 
sign of mitochondrial respiratory dysfunction after 24-h palmitate exposure. Palmitate lowers the 
glucose-sensitivity of mitochondrial respiration after 48-h exposure, whilst leaving basal oxygen 
consumption unaffected. Concomitant GSIS impairment mirrors this palmitate-induced respiratory 
defect, but, importantly, is caused to a large extent by elevated basal insulin secretion. A similar 
palmitate effect on basal insulin release is seen in INS-1E cells, where it is accompanied by a rise in 
intracellular calcium and where it is independent of palmitate-induced mitochondrial superoxide, 
unrelated to GSIS amplification and attenuated by palmitoleate. We conclude that mitochondrial 
dysfunction does not trigger palmitate-induced GSIS impairment under the glucolipotoxic 
conditions we applied, and that the observed bioenergetic changes are mostly coincidental, not 
predictive. 
EXPERIMENTAL 
Animals 
C57BL/6 mice (Jackson Laboratory) were housed in air conditioned rooms maintained at 26 ± 2 oC 
with a 12-h light and dark cycle. Animal protocols were approved by Plymouth University and 
Helmholtz Zentrum München in accordance with directive 2010/63/EU on the protection of animals 
used for scientific purposes.  
Islets  
Islets were isolated according to [19] from randomly selected 12-18 week old female or male mice 
by direct liberase injection into the common bile duct. Islets were incubated overnight under a 
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humidified carbogen atmosphere at 37 oC in Connaught Medical Research Laboratories (CMRL) 
medium containing 5.5 mmol/l glucose, 15 % (v/v) FBS, 50 units/ml penicillin, 50 μg/ml 
streptomycin, 500 μmol/l 2-mercaptoethanol, 17.8 mmol/l NaHCO3, and 2 mmol/l GlutaMAX. 
After this recovery period, islets were hand-picked at random into sterile Petri dishes containing 10 
ml serum-free CMRL with 11 mmol/l glucose, and then incubated ± palmitate for 24 or 48 h at 37 
˚C under carbogen. Palmitate was administered in conjugation to BSA as described previously [13] 
to yield an estimated free concentration of 40 nmol/l. Control islets were exposed to BSA alone. 
Cells 
INS-1E cells were maintained in RPMI medium according to [20]. Cells were seeded on multi-well 
plates at 6 x 104 cells/well and, at 70–80% confluence, exposed to BSA-conjugated palmitate and/or 
palmitoleate, or to BSA alone for 24 h in serum-free RPMI containing 4 or 11 mmol/l glucose ± 0.2 
mmol/l etomoxir. 
GSIS 
Islets were hand-picked into v-shape-bottomed 96-well plates (7 islets/well) containing 100 μl/well 
pre-warmed (37 oC) low-glucose Krebs-Ringer Bicarbonate (KRB) medium comprising 5.5 mmol/l 
glucose (i.e., fasting level in C57BL/6 mice [21]), 119 mmol/l NaCl, 4.7 mmol/l KCl, 2.5 mmol/l 
CaCl2, 1.2 mmol/l KH2PO4, 1.2 mmol/l MgCl2, 30.7 mmol/l NaHCO3, 10 mmol/l HEPES (pH 7.4), 
2 mmol/l GlutaMAX and 0.2 % (w/v) BSA. Islets were incubated at 37 oC under carbogen for 1 h, 
washed into fresh KRB and then incubated again for 1 h. Next, supernatant was collected and 
replaced with KRB containing 28 mmol/l glucose (i.e., a typical level to stimulate insulin release in 
mouse islets [19]) and after another 1-h incubation, supernatant was collected again. Supernatants 
were centrifuged at 10,000g and then assayed for insulin by ELISA (Mercodia, Uppsala, Sweden). 
Secreted insulin was normalised to islet DNA content as determined from PicoGreen fluorescence 
using Quant-iTTM PicoGreen® dsDNA Assay Kit (P11496, Life Technologies, UK). 
INS-1E cells seeded and palmitate-exposed on 96-well culture plates were washed and starved for 1 
h at 37 oC under air in low-glucose Krebs-Ringer Hepes (KRH) medium comprising 135 mmol/l 
NaCl, 3.6 mmol/l KCl, 10 mmol/l Hepes (pH 7.4), 0.5 mmol MgCl2, 1.5 mmol/l CaCl2, 0.5 mmol/l 
NaH2PO4, 2 mmol/l GlutaMAX, 2.5 mmol/l glucose and 0.2% (w/v) BSA. Medium was then 
replaced with fresh KRH and cells were incubated for 30 min on a shaking plate incubator (Labnet 
International, Oakham, UK) at 100 rpm. Next, supernatants were collected on ice and replaced with 
KRH containing 28 mmol/l glucose. In separate experiments, supernatants were replaced with KRH 
containing 50 mM KCl and 0.25 mmol/l diazoxide against a background of 2.5 or 28 mmol/l 
glucose. After another 30-min incubation, supernatants were collected on ice. Supernatants were 
centrifuged at 10,000g to pellet any detached cells and were then assayed for insulin by ELISA. 
Secreted insulin was normalised to cell density determined from DAPI fluorescence [15]. 
Mitochondrial respiration    
Islets were hand-picked into XF24 islet capture plates (Seahorse Bioscience, North Billerica, MA) 
at 20-30 islets/well in 500 μl/well DMEM containing 5.5 mmol/l glucose and 2 mmol/l GlutaMAX. 
Islets were contained by inserting pre-wetted capture discs into the wells [18]. Following a 1-h 
incubation at 37 oC under air, plates were transferred to an XF24 analyzer. OCRs were measured at 
37 oC in the absence and the cumulative presence of 28 mmol/l glucose, 10 μg/ml oligomycin and a 
mix of 2 μmol/l rotenone and 2 μmol/l antimycin A to determine, respectively, the glucose-
sensitivity of cellular respiration, coupling efficiency of oxidative phosphorylation, and non-
mitochondrial cellular oxygen uptake [13]. Basal respiration was calculated as the average of rate 
measurements 1-3 (see Figs 1G and 2G), glucose-stimulated respiration as measurement 10, 
oligomycin-insensitive respiration as the average of measurements 16-17, and non-mitochondrial 
respiration as the average of measurements 23-24. Non-mitochondrial OCRs were subtracted from 
other respiratory rates to calculate mitochondrial respiration. INS-1E cells were prepared for 
respiratory analysis as reported before [13].   
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Reactive oxygen species  
Mitochondrial ROS levels were determined in INS-1E cells by monitoring MitoSOX oxidation as 
described before [13] ± 20 μmol/l MnTMPyP (Cayman Chemical, Cambridge Bioscience, UK). 
Calcium  
Intracellular Ca2+ was quantified in INS-1E cells using Fura-2AM (Molecular Probes, Invitrogen). 
Cells seeded and palmitate-exposed on 96-well plates were incubated in glucose-free KRH for 1 h 
and then loaded with 1 μmol/l Fura-2AM for 40 min at 37 oC under air in the dark. Loaded cells 
were washed twice in glucose-free KRH and left in the dark for 20 min after which fluorescent 
products were measured in a multimode plate reader (PHERAstar FS, BMG Labtech). Total well 
fluorescence was detected in multi-chromatic well mode at λex/em = 380/510 nm and λex/em = 
340/510 nm for the ion-free and ion-bound indicator, respectively. The plate reader’s gain was set 
to 1500 and 1900 for 380/510 nm and 340/510 nm, respectively, and focal height was adjusted to 
5.0 mm. Fluorescence was measured at 3-sec intervals for 2.5 min and was calibrated by sequential 
injection of 5 μmol/l 4-bromo A-23187 (Life Technologies, UK) and 20 mmol/l EGTA to saturate 
and scavenge intracellular Ca2+, respectively. [Ca2+] was calculated from the 340/380 fluorescence 
ratio [22]. 
Statistical analysis 
Significance of mean differences was tested by unpaired Student’s t-test (Figs 1-3, 7) or 2-way 
ANOVA (Figs 4-6) using GraphPad Prism Version 6.0 for Mac OS X (GraphPad software, San 
Diego, CA, USA). Data are presented as means ± SEM. 
RESULTS     
Palmitate effects on insulin secretion precede mitochondrial dysfunction 
Consistent with the literature [11,12,23], 24-hr palmitate exposure attenuates GSIS in isolated 
mouse islets (Fig. 1A). This GSIS impairment is accounted for by statistically non-significant 
changes in absolute insulin release, i.e., by a marginal secretory increase at 5.5 mmol/l glucose (Fig. 
1B) and a somewhat larger decrease at 28 mmol/l (Fig. 1C). Importantly, palmitate has not altered 
islet respiration at this point in any way (Fig. 1G), which is reflected by unchanged absolute 
mitochondrial OCRs at 5.5 and 28 mmol/l glucose (Figs 1E and 1F, respectively). The islets’ 
respiratory response to glucose (~2.5-fold increase in mitochondrial oxygen uptake) thus remains 
unaffected after 24-h palmitate exposure (Fig. 1D). After 48-h, both palmitate stimulation of insulin 
release at 5.5 mmol/l glucose (Fig. 2B) and inhibition at 28 mmol/l (Fig. 2C) reach statistical 
significance. Consequently, GSIS impairment is more prominent after 48-h (Fig. 2A) than after 24-
h (Fig. 1A). Following prolonged exposure, palmitate has also lowered the islets’ respiratory 
response to glucose (Fig. 2G), which is reflected by a relatively low glucose sensitivity of 
mitochondrial respiration (Fig. 2D). The statistically significant effect of palmitate on this internally 
normalized respiratory parameter is exclusively owing to a non-significant inhibition of the absolute 
mitochondrial OCR at 28 mmol/l glucose (Fig. 2F). Oxygen uptake at 5.5 mmol/l glucose remains 
unaffected by palmitate, even after 48-h exposure (Fig. 2E). This unchanged oxygen consumption is 
noteworthy as palmitate insensitivity of basal mitochondrial respiration appears at odds with the 
palmitate-induced stimulation of basal insulin release (Fig. 2B). Any differences in absolute 
mitochondrial oxygen consumption between incubation times should be interpreted with caution as 
different islet preparations were used for the respective experiments. 
Glucose-stimulated oxygen consumption is lowered by 70 % ± 3.6 % in control mouse islets when 
the ATP synthase is inhibited with oligomycin (Figs. 1G and 2G, closed symbols). Such inhibition 
demonstrates that roughly two-thirds of total islet respiration is used to drive ATP synthesis whilst 
the other one-third is associated with either mitochondrial proton leak or non-mitochondrial oxygen 
consumption. When corrected for non-mitochondrial respiration, it transpires that the proportion of 
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mitochondrial respiratory activity used to make ATP (coupling efficiency of oxidative 
phosphorylation) is not changed by palmitate, irrespective of exposure time (Figs 1H and 2H). 
We have recently reported that palmitate impairs GSIS in INS-1E cells [13,14]. In line with our 
‘48-h’ islet data (Fig. 2), palmitate-induced GSIS annulment in INS-1E cells (Fig. 3A) appears the 
combined result of augmented insulin release at basal glucose (Fig. 3B) and decreased release at 28 
mmol/l glucose (Fig. 3C). Consequently, it seems that glucose attenuates rather than stimulates 
insulin secretion in palmitate-exposed cells, albeit non-significantly (cf. Fig. 5A). Concomitantly, 
palmitate dampens the glucose sensitivity of INS-1E mitochondrial respiration (Fig. 3D) by 
lowering absolute glucose-stimulated mitochondrial oxygen consumption (Fig. 3F). Importantly, 
however, palmitate leaves basal mitochondrial respiration unchanged (Fig. 3E). Palmitate-induced 
GSIS defects in INS-1E cells are thus disconnected, at least partly, from coinciding mitochondrial 
defects in oxidative phosphorylation. The cell data are consistent with our islet observations despite 
differences in exposure time and dose, which likely arise from differential palmitate accessibility. 
Palmitate stimulation of basal insulin secretion 
Palmitate-induced mitochondrial superoxide – Because mitochondrial ROS have been implicated in 
insulin secretion [7] and because palmitate increases mitochondrial superoxide in INS-1E cells [15], 
we assessed the effect of ROS scavenging on palmitate stimulation of basal insulin release (Fig. 4). 
In line with our recent findings [15], 24-h exposure of INS-1E cells to palmitate at high glucose 
increases the rate at which these cells oxidise MitoSOX (Fig. 4A), a mitochondria-targeted 
superoxide probe. MitoSOX oxidation in palmitate-exposed cells is lowered significantly by 20 
μmol/l MnTMPyP and is unaffected by this cell-permeant antioxidant [24] in control cells (Fig. 
4A). Interestingly, MnTMPyP does not prevent palmitate stimulation of basal insulin secretion, but 
tends to amplify it a little (Fig. 4B). Although palmitate-induced mitochondrial superoxide is not 
annulled entirely by MnTMPyP (Fig. 4A), the comparably low superoxide level reached is below 
the threshold at which damage to INS-1E cells appears [14,15]. These data suggest that palmitate 
stimulation of basal insulin release is not mediated by increased mitochondrial superoxide. Note 
that palmitate does not increase cytoplasmic superoxide levels under the applied conditions [15]. 
GSIS amplification – Next, we explored possible involvement of non-canonical GSIS amplifying 
pathways [10] in the stimulatory palmitate effect. Evidence for GSIS amplification typically comes 
from a glucose-dependent augmentation of KCl-provoked insulin release in the presence of KATP 
channel opener diazoxide [25], a phenomenon that has indeed been reported in INS-1E cells [20]. 
At 2.5 mmol/l glucose and 0.25 mmol/l diazoxide, 50 mmol/l KCl stimulates insulin release by our 
control cells almost 4.5-fold – this stimulation is not increased further at 28 mmol/l glucose (Fig. 
5A). Absolute KCl-induced insulin secretion, either at 2.5 or 28 mmol/l glucose, is not affected 
significantly by palmitate, and is indeed similar to the secretory rate provoked by palmitate alone 
(Fig. 5A). Diazoxide alone does not significantly affect basal insulin release, but it almost fully 
annuls insulin secretion at high glucose (P < 0.001) and tends to lower palmitate stimulation of 
basal insulin secretion (Fig. 5A). These data suggest a lack of GSIS amplification under our 
experimental conditions, which renders it unlikely that GSIS amplifying pathways are responsible 
for palmitate stimulation of basal insulin release.  
GSIS potentiation, lipid oxidation and palmitoleate protection – Acutely, palmitate has no effect on 
insulin release at a basal glucose level, but augments insulin secretion at stimulatory glucose and 
thus potentiates GSIS [26,27]. It is unlikely, however, that a potentiation-like mechanism underlies 
palmitate stimulation of basal insulin release after 24 h, as the effect is independent of the glucose 
level during exposure – stimulation occurs both against a 4 and 11 mmol/l glucose background (Fig. 
5B). Furthermore, inhibiting mitochondrial beta oxidation with etomoxir does not significantly 
affect this stimulation, at 4 or 11 mmol/l glucose (Fig. 5B), ruling out mechanistic involvement of 
palmitate oxidation. In line with the comparably harmless effects of monounsaturated NEFAs on 
beta cell behaviour [28] palmitoleate does not increase basal insulin secretion and indeed attenuates 
the palmitate-induced stimulation (Fig. 5C). 
Ac
ce
pt
d
M
an
us
cr
ip
t
© 2015 The Author(s) Archiving permitted only in line with the archiving policy of Portland Press Limited. All other rights reserved.
 
7 
Calcium and insulin content – Ca2+ was measured in intact INS-1E cells with Fura-2AM, which 
was calibrated in individual experiments by sequential addition of the ionophore 4-bromo A23187 
and EGTA (Fig 6A). Cells grown in fully supplemented RPMI contain 95 nmol/l ± 20 nmol/l Ca2+ 
(Fig 6B), a level that is typical for insulinoma cells [29] and that appears somewhat increased (to 
160 ± 12 nmol/l) in serum-depleted, BSA-exposed control cells (Fig. 6B) without notable effect on 
insulin secretion (data not shown). Importantly, palmitate causes a further rise in Ca2+ to 210 ± 15 
nmol/l (Fig 6B). This Ca2+ increase suggests that palmitate stimulation of basal insulin secretion is 
linked to exocytotic events [30] and is not simply owing to insulin leakage from dead or damaged 
cells [16]. The insulin content of INS-1E cells is not affected significantly by palmitate, although 
the average level tends to be increased (Fig 7A). In mouse islets, on the other hand, 48-h palmitate 
exposure more than halves insulin content when levels are normalised to DNA (Fig 7B). 
DISCUSSION 
Real-time functional analysis of cellular bioenergetics has become relatively common over the last 
decade or so [17], but the application of XF technology to probe mitochondrial respiratory activity 
of isolated pancreatic islets has, to our knowledge, been limited to little more than a handful of 
studies [9,18,27,31-33]. The results reported in this paper highlight the strength of functional islet 
respiratory measurements as they provide novel insight in mitochondrial engagement with 
pancreatic beta cell glucolipotoxicity (Fig. 8). Our findings reveal that palmitate-induced GSIS 
impairment is disconnected from coincident mitochondrial dysfunction. Furthermore, the data 
substantiate published palmitate effects on basal insulin release and provide further clues as to the 
molecular nature of such effects. 
Mitochondrial involvement in beta cell glucolipotoxicity 
It is well established that prolonged exposure of pancreatic beta cells to elevated levels of glucose 
and NEFAs is detrimental to the function and viability of these cells [34]. Possible molecular 
defects that underlie glucolipotoxic beta cell death and secretory dysfunction are in abundance, but 
the relative importance of the multifarious fatty-acid-induced cellular defects remains unclear, as 
indeed do their causal relations. Glucolipotoxicity likely influences the bioenergetics of beta cells 
since UCP2 has been reported to mediate palmitate-induced insulin secretory defects in mice and 
isolated islets [35,36]. A proposed protective role against oxidative stress [37], on the other hand, 
would predict that UCP2 activity ameliorates glucolipotoxic damage instead. Studying INS-1E 
cells, we have shown that palmitate triggers ROS generation and oxidative phosphorylation defects, 
functional mitochondrial changes that coincide with cell loss and attenuated GSIS [13]. In our 
hands, UCP2 is not involved with mitochondrial superoxide-mediated cell loss [15] or with the 
mitochondrial respiratory defects that correlate with GSIS impairment [14]. The INS-1E cell 
respiratory data shown in Fig. 3 are consistent with our previous reports [13,14] in so much that the 
deleterious palmitate effect on the normalised mitochondrial respiratory response to glucose - i.e., 
an intrinsic mitochondrial defect (Fig. 3D) - is echoed by a similar negative effect of palmitate on 
the normalised response of insulin secretion to glucose (Fig. 3A). In mouse islets exposed to 
palmitate for 48 h, the situation is the same: impaired GSIS (Fig. 2A) correlates with a decreased 
normalised glucose respiratory response (Fig. 2D). Dissection of these internally normalised 
parameters into their absolute components, however, sheds important new light on these apparent 
relations between mitochondrial respiratory dysfunction and impaired GSIS. Both in islets and 
cells, significant increases in basal insulin release (Figs 2B and 3B, respectively) contribute to 
palmitate-impaired GSIS, whilst basal mitochondrial respiration is unaffected by palmitate in both 
systems (Figs 2E and 3E, respectively). Disconnection between palmitate effects on mitochondrial 
respiration and insulin secretion is further evident when islets are exposed to palmitate for only 24 h 
after which GSIS impairment (Fig 1A) emerges without any sign of mitochondrial respiratory 
dysfunction (Figs 1D-H). Similarly, 48-h exposure to palmitoleate, the monounsaturated, less 
harmful equivalent of palmitate, impairs islet GSIS without change in glucose-stimulated 
mitochondrial respiration (data not shown). In INS-1E cells, palmitoleate prevents a significant 
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increase in basal insulin release by palmitate (Fig. 5C) but does not affect absolute basal 
mitochondrial respiration, either with or without palmitate [13]. 
Mechanism by which palmitate increases basal insulin release 
Stimulatory effects of palmitate on basal insulin secretion (Figs 2B and 3B) are well documented in 
cells [38] and in rodent [11,39] and human [12] islets. Importantly, individuals suffering from Type 
2 diabetes also exhibit elevated basal insulin release [40]. Although the phenomenon is thus not 
new by any means, its molecular nature has not been established firmly. Our results render a 
metabolic origin of the palmitate effect unlikely as stimulation of basal insulin release is not caused 
by boosted mitochondrial ATP production (Figs 1-3), increased fatty acid oxidation (Fig. 5B), 
heightened superoxide formation (Fig 4), or by GSIS amplification/potentiation (Fig 5). As 
palmitate increases basal Ca2+ (Fig 6), stimulated insulin release is not owing to non-specific 
leakage from damaged or dying cells, but more likely to altered electrical activity of beta cells. 
Indeed, palmitate effects on KATP and voltage-gated Ca2+ channels have been reported [23,30,39]. 
Diazoxide tends to partially reverse palmitate stimulation of basal insulin secretion (Fig 5A), which 
would be consistent with a direct action on KATP channels given the lack of palmitate effect on 
oxidative phosphorylation at basal glucose (Fig 3E). An additional direct action on Ca2+ channels 
cannot be excluded at present. 
Mitochondrial activity as biomarker 
In light of islet cell transplantation as promising treatment for Type 1 diabetes patients, the need for 
reliable assays ascertaining functional islet integrity prior to transplantation is increasing [16]. 
Assays that evaluate mitochondrial function show much promise in this respect [16] and the islet 
OCR, in particular, correlates positively with transplant outcomes in mice and pigs when 
normalised to islet size [41], and, without such normalisation, in humans too [42]. Bioenergetic 
parameters correlate generally much better with clinical transplant outcome than GSIS measures 
[16]. Our data may explain this perhaps surprising ‘prediction discrepancy’ as they demonstrate that 
mitochondrial oxygen consumption is not proportional to insulin secretion under all circumstances. 
For example, ‘early’ palmitate-induced GSIS impairment in isolated mouse islets (Fig 1A) is not 
foreshadowed by any respiratory changes (Figs 1D-H). As mitochondrial defects may equally arise 
without negative consequences for GSIS [33], we feel some caution is due when using ‘bioenergetic 
health’ as sole predictor of islet transplantation outcome. 
Concluding remarks 
Although mitochondria are central to the main role of pancreatic beta cells, i.e., coupling glucose 
sensing to insulin release, our results show that altered mitochondrial function does not necessarily 
predict GSIS changes. More work is needed to identify the roots of glucolipotoxic defects in 
oxidative phosphorylation reported here and elsewhere, to identify the molecular nature of the lipid 
species responsible for such defects, and to clarify their consequences for beta cell physiology. 
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LEGENDS 
Fig.1: 24-h palmitate exposure impairs islet GSIS without sign of mitochondrial dysfunction. 
Insulin secretory and mitochondrial respiratory responses to glucose were normalised, respectively, 
to basal insulin secretion (A) and basal mitochondrial oxygen consumption (D). Absolute insulin 
secretion and mitochondrial respiratory rates were determined at both 5.5 (B and E) and 28 mmol/l 
(C and F) glucose by normalising rates to DNA content. As described in the Methods, respiratory 
rates and coupling efficiencies (H) were calculated from extracellular flux traces (G) in which 
glucose (G28), oligomycin (OLI), and a mixture of rotenone and antimycin A (R/A) were added as 
indicated. Open and closed symbols: islets exposed to palmitate or BSA, respectively (n = 7-13 
wells from 3-4 assays). 
Fig.2: 48-h palmitate exposure stimulates basal islet insulin secretion without effect on basal 
mitochondrial respiration. Insulin secretory and mitochondrial respiratory responses to glucose 
were normalised, respectively, to basal insulin secretion (A) and basal mitochondrial oxygen 
consumption (D). Absolute insulin secretion and mitochondrial respiratory rates were determined at 
both 5.5 (B and E) and 28 mmol/l (C and F) glucose by normalising rates to DNA content. As 
described in the Methods, respiratory rates and coupling efficiencies (H) were calculated from 
extracellular flux traces (G) in which glucose (G28), oligomycin (OLI), and a mixture of rotenone 
and antimycin A (R/A) were added as indicated. Open and closed symbols: islets exposed to 
palmitate or BSA, respectively (n = 7-13 wells from 3-4 assays). 
Fig.3: Palmitate-induced GSIS impairment is disconnected from mitochondrial dysfunction in 
INS-1E cells. Secretory and respiratory responses to glucose were normalised, respectively, to basal 
insulin secretion (A) and basal mitochondrial oxygen uptake (D). Absolute insulin secretion and 
mitochondrial respiratory rates were determined by normalising the respective activities to INS-1E 
cell number both in the absence (B and E) and the presence (C and F) of 28 mmol/l glucose. Open 
and closed bars: 24-h exposure to palmitate or BSA, respectively, at 11 mmol/l glucose (n = 3-4). 
Fig.4: Effect of palmitate on basal insulin release by INS-1E cells is unaffected by scavenging 
ROS. MitoSOX oxidation (A), measured as time-dependent increase in relative fluorescence units, 
RFU, and insulin secretion (B) were normalised to cell number and measured ± 20 μmol/l 
MnTMPyP. Open and closed bars: 24-h exposure to palmitate or BSA, respectively, at 11 mmol/l 
glucose (n = 3-4). 
Fig.5: Palmitate stimulation of basal insulin release by INS-1E cells does not involve GSIS 
amplification, GSIS potentiation or lipid oxidation, but is attenuated by palmitoleate. Cells 
were exposed for 24 h to palmitate (open bars in panels A and B), palmitoleate ± palmitate, or BSA 
(black bars in panels A and B,) at 11 (panels A and C), or at 4 or 11 mmol/l glucose (panel B – G4 
and G11, respectively) ± 0.2 mmol/l etomoxir (ETO). After 1-h glucose starvation, insulin secretion 
was measured at 2.5 (panels B and C), or at 2.5 or 28 mmol/l glucose (panel A – G2.5 and G28, 
respectively). Diazoxide (DZ) and KCl were included in the assay at 0.25 and 50 mmol/l, 
respectively, as indicated. Insulin secretion rates were normalised to cell number (n = 3-8).  
Fig.6: Palmitate increases the basal calcium level of INS-1E cells. Intracellular calcium levels 
(B) were calculated from background-corrected Fura-2 AM fluorescence intensity ratios (A – 
340/380 nm excitation) in INS-1E cells grown in fully-supplemented RPMI (‘serum’, open 
squares), or in serum-deprived cells exposed for 24 h to palmitate or BSA (open and black circles, 
respectively) at 11 mmol/l glucose. Cells were loaded with 1 μmol/l Fura-2 AM and fluorescence 
was measured at 3-sec intervals for 3 min. Average fluorescence ratios measured over the first 60 
sec of the assay were calibrated by sequential addition of 5 μmol/l 4-bromo A-23187 (‘ionophore’) 
and 20 mmol/l EGTA in every assay to saturate and deplete calcium levels, respectively (n = 6). 
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Fig.7: Effect of palmitate on insulin content. INS-1E cells (A) and mouse islets (B) were exposed 
for 24 h and 48 h, respectively, to palmitate or BSA (open and black bars, respectively) at 11 
mmol/l glucose (n = 2-3). Values were normalised to cell number (A) or DNA content (B).  
Fig.8: Palmitate-induced GSIS impairment is disconnected from mitochondrial respiratory 
dysfunction. Control islets (BSA) exhibit ‘normal’ mitochondrial respiration and GSIS phenotypes 
as they increase both their mitochondrial OCR and insulin secretion rate in response to high 
glucose. 24-h palmitate exposure (PA24h) impairs GSIS exclusively because of a lowered insulin 
secretion at high glucose - mitochondrial respiration is unaffected at this point. 48-h palmitate 
exposure (PA48h) impairs both mitochondrial respiration and GSIS because of a dampened glucose 
response. GSIS impairment results in part from palmitate-induced stimulation of basal insulin 
release - the basal mitochondrial OCR remains unaffected by palmitate.
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